Decoy Therapeutics Inc.
DCOY· Nasdaq
DCOYDecoy Therapeutics Inc.
Filed Nov 4, 2015 · 10-Q · 35 days after period end · 0001615219-15-000073
| Metric | Q3 2015 | Q3 2014 |
|---|---|---|
| Revenue | $0.00 | — |
| Net Income | -$8.15M | -$1.99M |
| EPS Diluted | -$0.53 | -$1.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Decoy Therapeutics Inc. · CIK 1615219 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Nov 4, 2015 · 35 d after period end
